Research - Page 15 of 719 Posts on Medivizor

Evaluating the effectiveness of transanal endoscopic microsurgery for the treatment of early rectal cancer in patients over 60 years old with high surgical risk.

Posted by Medivizor on Jan 3, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness of transanal endoscopic microsurgery (TEM) for the treatment of early rectal cancer (RC) in patients over 60 years old with high surgical risk. The data showed that TEM is a reliable and effective treatment option in high-risk patients over 60 years old. Some background Rectal cancer (RC) is one of...

Evaluating the effect of patient-reported physical and mental health status before PCI/CABG on their long-term outcomes

Posted by Medivizor on Jan 3, 2023 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effect of patient-reported physical and mental health status before revascularization procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) on their long-term outcomes in patients with coronary artery disease (CAD). The data showed that...

Comparing the effects of a ketogenic diet versus a Mediterranean diet on glucose control in patients with prediabetes and type 2 diabetes.

Posted by Medivizor on Jan 3, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of a ketogenic diet (KD) versus a Mediterranean diet (MD) on glucose control in patients with prediabetes and type 2 diabetes (T2D). The data showed that the less restrictive MD was as effective in controlling glucose as a KD and likely more likely to be maintained in the long term. There...

Evaluating the effectiveness and safety of different platinum-based chemotherapy regimens given after surgery for the treatment of early-stage resected NSCLC.

Posted by Medivizor on Jan 3, 2023 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of different platinum-based chemotherapy regimens given after surgery for the treatment of early-stage resected non-small cell lung cancer (NSCLC). The authors concluded that the combination of cisplatin (Platinol)-vinorelbine (Nevelbine) improved the outcomes of these patients. Also, the...

Evaluating the effectiveness of different ovarian stimulation protocols for patients with poor ovarian response.

Posted by Medivizor on Jan 3, 2023 in Infertility | 0 comments

In a nutshell This study evaluated the effectiveness of different ovarian stimulation protocols for patients with poor ovarian response (POR). The data showed that delayed start gonadotropin-releasing hormone (GnRH) antagonist and microdose GnRH agonist were the two most effective regimens for the treatment of these patients. Some background Many...

Comparing the effectiveness and safety of combined therapy of atezolizumab with nab-paclitaxel in patients with triple negative breast cancer

Posted by Medivizor on Jan 3, 2023 in Breast cancer | 0 comments

In a nutshell The study compared the effectiveness and safety of atezolizumab (Tecentriq) and nab-paclitaxel (Abraxane) combined therapy with nab-paclitaxel alone in patients with triple-negative breast cancer (TNBC). The study found that combined therapy was more effective than single therapy but it had more serious side effects in these...

Evaluating the effectiveness of massage therapy for chemotherapy-induced nerve disease

Posted by Medivizor on Jan 3, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of massage therapy for chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast and gastrointestinal (GI) cancer. The main finding of the study was that intensive massage therapy 3 times a week showed promising results in these patients. Some background There are many...

Evaluating the effectiveness of massage therapy for chemotherapy-induced nerve disease

Posted by Medivizor on Jan 3, 2023 in Colorectal cancer | 0 comments

In a nutshell The study evaluated the effectiveness of massage therapy for chemotherapy-induced peripheral neuropathy (CPIN) in patients with breast and gastrointestinal (GI) cancer. The main finding of the study was that intensive massage therapy 3 times a week showed promising results in these patients. Some background There are many cancer...

Evaluating treosulfan vs reduced-intensity busulfan conditioning for allogeneic hematopoietic cell transplantation in older patients with acute myeloid leukemia

Posted by Medivizor on Dec 31, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to compare the outcomes of allogeneic hematopoietic cell transplant (alloHCT) for older patients with acute myeloid leukemia (AML) using treosulfan (Trecondi) compared to reduced intensity busulfan (Myleran) conditioning. This study concluded that treosulfan conditioning appears to be more suitable for...

How effective and safe is rituximab biosimilar HLX01 in patients with moderate to severe rheumatoid arthritis?

Posted by Medivizor on Dec 31, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated the effectiveness and safety of rituximab (Rituxan) biosimilar HLX01 combined with methotrexate (MTX; Trexall) in patients with moderate to severe rheumatoid arthritis (RA) following inadequate responses to MTX. The study showed that HLX01 added to MTX resulted in improvements compared to placebo in these...

How beneficial is the addition of metformin to insulin therapy for adolescents with type 1 diabetes?

Posted by Medivizor on Dec 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effectiveness and safety of adding metformin (Glucophage) to insulin therapy in the treatment of adolescents with type 1 diabetes (T1D). The study showed that the use of metformin in these patients resulted in improved blood glucose control and body mass index (BMI) with an increased risk of...

Is the use of sodium-glucose cotransporter 2 inhibitors related to the occurrence of eye diseases in patients with type 2 diabetes?

Posted by Medivizor on Dec 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the link between sodium-glucose cotransporter 2 inhibitors (SGLT2is) and eye (ocular) diseases in patients with type 2 diabetes (T2D). The data showed that there was no link between the occurrence of eye diseases and SGLT2is in these patients. Some SGLT2is such as ertugliflozin (Steglatro) and empagliflozin...

Research Posts on Medivizor

Evaluating the effectiveness of transanal endoscopic microsurgery for the treatment of early rectal cancer in patients over 60 years old with high surgical risk.

Evaluating the effect of patient-reported physical and mental health status before PCI/CABG on their long-term outcomes

Comparing the effects of a ketogenic diet versus a Mediterranean diet on glucose control in patients with prediabetes and type 2 diabetes.

Evaluating the effectiveness and safety of different platinum-based chemotherapy regimens given after surgery for the treatment of early-stage resected NSCLC.

Evaluating the effectiveness of different ovarian stimulation protocols for patients with poor ovarian response.

Comparing the effectiveness and safety of combined therapy of atezolizumab with nab-paclitaxel in patients with triple negative breast cancer

Evaluating the effectiveness of massage therapy for chemotherapy-induced nerve disease

Evaluating the effectiveness of massage therapy for chemotherapy-induced nerve disease

Evaluating treosulfan vs reduced-intensity busulfan conditioning for allogeneic hematopoietic cell transplantation in older patients with acute myeloid leukemia

How effective and safe is rituximab biosimilar HLX01 in patients with moderate to severe rheumatoid arthritis?

How beneficial is the addition of metformin to insulin therapy for adolescents with type 1 diabetes?

Is the use of sodium-glucose cotransporter 2 inhibitors related to the occurrence of eye diseases in patients with type 2 diabetes?

Categories

Recent Posts

Archives

Research Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email